We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

79 hedge funds and large institutions have $577M invested in Bicycle Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more capital invested

Capital invested by funds: $381M → $577M (+$196M)

7.05% more ownership

Funds ownership: 76.55% → 83.59% (+7%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more call options, than puts

Call options by funds: $18K | Put options by funds: $18K

2% less funds holding

Funds holding: 81 → 79 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

24% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 29

Holders
79
Holders Change
-2
Holders Change %
-2.47%
% of All Funds
1.36%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
8
Increased
22
Reduced
29
Closed
10
Calls
$18K
Puts
$18K
Net Calls
–
Net Calls Change
-$1.58M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$47.3M
2
BBA
Baker Bros. Advisors
New York
+$20.1M
3
CS
Candriam SCA
Luxembourg
+$9.46M
4
LGM
Logos Global Management
California
+$7.14M
5
SC
Samlyn Capital
New York
+$6.04M

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$7.88M
2
Citadel Advisors
Citadel Advisors
Florida
-$4.64M
3
Millennium Management
Millennium Management
New York
-$4.54M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.51M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$3.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$2.92M +$1M +42,231 +51%
DCM
27
DAFNA Capital Management
California
$2.84M -$214K -9,000 -7%
Goldman Sachs
28
Goldman Sachs
New York
$2.45M -$1.17M -49,035 -32%
BG
29
Bellevue Group
Switzerland
$2.28M +$326K +13,700 +16%
TCM
30
Tekla Capital Management
Massachusetts
$2.06M +$1.63M +68,611 +342%
PHP
31
Parkman Healthcare Partners
Connecticut
$1.89M +$498K +20,938 +35%
ECM
32
ExodusPoint Capital Management
New York
$1.83M -$2.46M -103,443 -57%
VOYA Investment Management
33
VOYA Investment Management
Georgia
$1.58M +$1.61M +67,747 New
UOC
34
UBS O'Connor
Illinois
$1.57M +$238K +10,000 +17%
AllianceBernstein
35
AllianceBernstein
Tennessee
$1.48M -$1.64M -68,868 -52%
Voloridge Investment Management
36
Voloridge Investment Management
Florida
$1.46M -$1.44M -60,383 -49%
Two Sigma Investments
37
Two Sigma Investments
New York
$1.15M -$7.88M -331,154 -87%
Citadel Advisors
38
Citadel Advisors
Florida
$1.13M -$4.64M -194,930 -80%
HCA
39
Harbor Capital Advisors
Illinois
$1.06M -$128K -5,360 -11%
LSA
40
L & S Advisors
California
$995K +$1.02M +42,765 New
Victory Capital Management
41
Victory Capital Management
Texas
$834K +$58.2K +2,445 +7%
UBS Group
42
UBS Group
Switzerland
$662K +$369K +15,509 +120%
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$597K – – –
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$559K +$137K +5,773 +32%
EHI
45
Eagle Health Investments
Connecticut
$547K – – –
AP
46
AtonRa Partners
Switzerland
$502K -$33.9K -1,425 -6%
Geode Capital Management
47
Geode Capital Management
Massachusetts
$498K +$245K +10,287 +92%
SSA
48
Schonfeld Strategic Advisors
New York
$483K -$11.9K -500 -2%
OCA
49
Octagon Capital Advisors
New York
$465K +$476K +20,000 New
AA
50
ALPS Advisors
Colorado
$376K -$33.4K -1,404 -8%
1
2
3 4

BCYC Hedge Fund Activity: Q3 2022 in Review

79 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q3 2022, worth a combined $577M — up 51% from $381M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of BCYC and 8 opened new positions — a net loss of 2 holders — while 29 trimmed existing stakes and 22 added.

The largest buyer was Janus Henderson Group, adding an estimated $47.3M. The largest seller was Two Sigma Investments, cutting an estimated $7.88M.

  • 79 institutional investors held Bicycle Therapeutics (BCYC) as of Q3 2022, down from 81 in Q2 2022.
  • Funds reported $577M of Bicycle Therapeutics stock for Q3 2022, up 51% quarter-over-quarter.
  • 8 funds opened new Bicycle Therapeutics positions in Q3 2022 and 10 closed out, a net change of -2 holders.
  • The largest Bicycle Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $47.3M added.
  • The largest Bicycle Therapeutics seller in Q3 2022 was Two Sigma Investments, an estimated $7.88M sold.

Based on aggregated 13F filings for Q3 2022.